The BET Protein BRD2 Cooperates with CTCF to Enforce Transcriptional and Architectural Boundaries-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The BET Protein BRD2 Cooperates with CTCF to Enforce Transcriptional and Architectural Boundaries

Published:2017-04 Issue:1 Volume:66 Page:102-116.e7
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Hsu Sarah C.,Gilgenast Thomas G.,Bartman Caroline R.,Edwards Christopher R.,Stonestrom Aaron J.,Huang Peng,Emerson Daniel J.,Evans Perry,Werner Michael T.,Keller Cheryl A.,Giardine Belinda,Hardison Ross C.,Raj Arjun,Phillips-Cremins Jennifer E.,Blobel Gerd A.

Funder

NCI

Patel Family Scholar Award

NIH

NIH New Innovator Award

Alfred P. Sloan Foundation

NSF-NIGMS

DiGaetano family

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference74 articles.

1. Genome-wide localization of small molecules;Anders;Nat. Biotechnol.,2014

2. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer;Asangani;Nature,2014

3. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses;Belkina;J. Immunol.,2013

4. The first bromodomain of the testis-specific double bromodomain protein Brdt is required for chromocenter organization that is modulated by genetic background;Berkovits;Dev. Biol.,2011

5. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias;Bolstad;Bioinformatics,2003

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers Initiative;Genes;2024-09-09

2. Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia;Scientific Reports;2024-04-20

3. Bromodomain and Extraterminal Domain Protein 2 in Multiple Human Diseases;Journal of Pharmacology and Experimental Therapeutics;2024-04-02

4. Successes and challenges in the development of BD1-selective BET inhibitors: a patent review;Expert Opinion on Therapeutic Patents;2024-03-11

5. Assessing the impact of Brd2 depletion on chromatin compartmentalization;2024-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3